Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal Testing

J Investig Allergol Clin Immunol. 2021 Dec 21;31(6):526-527. doi: 10.18176/jiaci.0720. Epub 2021 Jun 16.

Authors

J Pickert^{1

2}, I Hennighausen², S Mühlenbein², C Möbs¹, W Pfützner^{1

2}

Affiliations

¹ Clinical & Experimental Allergology, Department of Dermatology and Allergology, Philipps-Universität Marburg, Marburg, Germany.
² Department of Dermatology and Allergology, Allergy Center Hessen, University Medical Center Marburg, Marburg, Germany.

PMID: 34132638
DOI: 10.18176/jiaci.0720

No abstract available

Keywords: Allergy; COVID-19; PEG; Skin testing; Vaccine.

Publication types

Case Reports

MeSH terms

BNT162 Vaccine / adverse effects*
COVID-19 / prevention & control*
Cross Reactions
Female
Humans
Hypersensitivity, Immediate / chemically induced*
Intradermal Tests
Polyethylene Glycols / adverse effects*
Young Adult

Substances

Polyethylene Glycols
BNT162 Vaccine